Simultaneously, the state of calorie deficit itself creates a catabolic environment, where the body breaks down tissue to meet energy demands
Furthermore, defining the optimal treatment duration and enhancing analgesic strategies remain necessary
When GLP-1 medications are contraindicated Some patients cannot tolerate GLP-1 medications due to severe gastrointestinal side effects, a personal or family history of medullary thyroid carcinoma, or active gallbladder disease
Patients should re-escalate to the 2.4 mg dose if tolerated
For estrogen pathways, GHKCu appears to influence aromatase activity in some models, with potential to lower local estrogen production where excess drives pathology
It would reshape the market for treating specific cardio-metabolic conditions, potentially shrinking the downstream commercial opportunity if the CV risk baseline was reset by an upstream intervention focussed on weight management